Preparation and testing of homocubyl amines as therapeutic NMDA receptor antagonists

Medicinal Chemistry Research

Volumn 22, Issue 1, 2013, Pages 360-366

  Sklyarova, Anna S ^a   Rodionov, Vladimir N ^a   Parsons, Christopher G ^b   Quack, Günter ^b   Schreiner, Peter R ^c   Fokin, Andrey A ^a,c  

^a NATIONAL TECHNICAL UNIVERSITY OF UKRAINE   (Ukraine)

^b MERZ PHARMACEUTICALS GMBH   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Bishomocubyl 10 amine; Cubylamine; Homocubyl 9 amine; Memantine; NMDA antagonist; Trishomocubyl 4 amine

Indexed keywords

BISHOMOCUBYL 10 AMINE; CHLORIDE; DIZOCILPINE; HOMOCUBYL 9 AMINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; TRISHOMOCUBYL 4 AMINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; RAT; RECEPTOR BINDING;

EID: 84872015075     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0029-7     Document Type: Article

References (30)

1. Chakrabarti JK, Hotten TM, Sutton S, Tupper DE (1976) Adamantane and protoadamantanealkanamines as potential anti-parkinson agents. J Med Chem 19:967-969
2. 4,7] nonane derivatives. J Org Chem 35:3860-3867
3. Chen HSV, Lipton SA (2006) The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem 97(6):1611-1626
4. Danysz W, Parsons CG (2003) The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Int J Geriatr Psychiatry 18:S23-S32
5. Danysz W, Parsons CG, Kornhuber J, Schmidt WJ, Quack G (1997) Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents: preclinical studies. Neurosci Biobehav Rev 21(4):455-468
6. Duque MD, Camps P, Profire L, Montaner S, Vázquez S, Sureda FX, Mallol J, López-Querol M, Naesens L, De Clercq E, Prathalingam SR, Kelly JM (2009) Synthesis and pharmacological evaluation of (2-oxaadamant-1-yl)amines. Bioorg Med Chem 17:3198-3206
7. Eaton PE, Cole TW Jr (1964) Cubane. J Am Chem Soc 86:3157-3158
8. 5,9]undecan-4- one). J Chem Soc Chem Commun 978-979
9. Eaton PE, Ravi Shankar BK, Price GD, Pluth JJ, Gilbert EE, Alster J, Sandus O (1984) Synthesis of 1,4-dinitrocubane. J Org Chem 49:185-186
10. Foster AC, Wong EHF (1987) The novel anticonvulsant MK-801 binds to the activated state of the N-Methyl-D-aspartate receptor in rat brain. Br J Pharmacol 91:403-409
11. Hirao K, Miura H, Yonemitsu O (1977) Beckmann rearrangement of bis-homocubyl oximes. Heterocycles 7:857-862
12. Ingalsbe ML, St. Denis JD, Gleason JL, Savage GP, Priefer R (2010) Synthesis of a novel chiral cubane-based Schiff base ligand and its application in asymmetric nitro-aldol (Henry) reactions. Synthesis 1:98-102
13. Javitt DC, Zukin SR (1989) Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels. Mol Pharmacol 35:387-393
14. Johnson KA, Conn PJ, Niswender CM (2009) Glutamate receptors as therapeutic targets for Parkinson's disease. CNS Neurol Disord Drug Targets 8:475-491
15. Klunder ALH, Zwanenburg B (1972) Chemistry of strained polycyclic compounds 3. Synthesis of cubane and homocubane alcohols. Tetrahedron 28(15):4131-4138
16. Mehta G, Srikrishna A, Suri SC (1980) Convenient preparation routes to 1,8-bis-homocubane, 1,8-bis-homocubanone, snoutanone, and homocubanone. J Org Chem 45(26):5375-5377
17. 4,8]decane). J Org Chem 42:2985-2988
18. 3)-trishomocubane-4-amine hydrochloride hydrate. Zeit f Krist 210(11):861-864
19. 5,9]undecan-8-ol. S Afr J Chem 32:45-48
20. Parsons CG, Gruner R, Rozental J, Millar J, Lodge D (1993) Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology 32(12):1337-1350
21. Parsons CG, Quack G, Bresink I, Baran L, Przegalinski E, Kostowski W, Krzascik P, Hartmann S, Danysz W (1995) Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology 34(10):1239-1258
22. Parsons CG, Danysz W, Bartmann A, Spielmanns P, Frankiewicz T, Hesselink M, Eilbacher B, Quack G (1999a) Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization. Neuropharmacology 38(1):85-108
23. Parsons CG, Danysz W, Quack G (1999b) Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist: a review of preclinical data. Neuropharmacology 38(6):735-767
24. Parsons CG, Stoffler A, Danysz W (2007) Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutarnatergic system-too little activation is bad, too much is even worse. Neuropharmacology 53(6):699-723
25. Rammes G, Danysz W, Parsons CG (2008) Pharmacodynamics of memantine: an update. Curr Neuropharmacol 6:55-78
26. Shioiri T, Ninomiya K, Yamada S (1972) Diphenylphosphoryl azide. New convenient reagent for a modified Curtius reaction and for peptide synthesis. J Am Chem Soc 94:6203-6205
27. Sklyarova AS, Rodionov VN, Fokin AA (2009) Convenient preparative synthesis of pentacyclo[5.3.0.02,5.03,9.04,8]decane (c-2 bishomocubane). Russ. J Org Chem 45(11):1633-1636
28. Stamatiou G, Foscolos GB, Fytas G, Kolocouris N, Pannecouque C, Witvrouw M, Padalko E, Neyts J, De Clerq E (2003) Heterocyclic rimantadine analogues with antiviral activity. Bioorg Med Chem 11:5485-5492
29. Wang Y, Eu J, Washburn M, Gong T, Chen H-SV, James WL, Lipton SA, Stamler JS, Went GT, Porter S (2006) The pharmacology of aminoadamantane nitrates. Curr Alzheimer Res 3:201-204
30. Wenk GL, Parsons CG, Danysz W (2006) Potential role of N-methyl-D-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine. Behav Pharmacol 17:411-424